https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-18 / J Transl Med 2013 Jun;11:149
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-18 / J Transl Med 2013 Jun;11:1492013-06-18 00:00:002019-02-15 08:52:12A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-04 / J Clin Oncol 31, 2013 (suppl; abstr e20042)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-04 / J Clin Oncol 31, 2013 (suppl; abstr e20042)2013-06-04 11:44:592019-07-17 11:45:20Biochemical and immunologic markers in patients with metastatic melanoma treated with chemotherapy and dendritic cell vaccine.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-04 / Oncol Lett 2013 Aug;6(2):537-541
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-04 / Oncol Lett 2013 Aug;6(2):537-5412013-06-04 00:00:002019-02-15 08:39:47Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3040)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3040)2013-06-03 11:37:322019-07-17 11:38:06Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-932013-06-03 00:00:002013-06-03 00:00:00Re-irradiation and hyperthermia after surgery for recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3049)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3049)2013-06-03 00:00:002013-06-03 00:00:00Phase II study of dendritic cell vaccination combined with recombinant adenovirus-p53 in treatment for patients with advanced pancreatic carcinoma.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)2013-06-03 00:00:002021-08-09 07:55:21Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3100)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3100)2013-06-03 00:00:002013-06-03 00:00:00Role of mesenchymal stem cells in delivering Newcastle disease virus to glioma cells and glioma stem cells and enhancing the oncolytic effect of the virus by secreting TRAIL.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-02 / Cancer Immunol. Immunother. 2013 Aug;62(8):1381-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-02 / Cancer Immunol. Immunother. 2013 Aug;62(8):1381-922013-06-02 00:00:002019-02-15 08:50:41Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-01 / J Clin Oncol 31, 2013 (suppl; abstr 3029)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-01 / J Clin Oncol 31, 2013 (suppl; abstr 3029)2013-06-01 00:00:002021-08-09 07:52:56Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: Results of phase I study.
